Evidence map›Paper›PMID 30157893›Full record

ReviewItalian journal of pediatrics2018

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.

Alessandra Marchesi, Isabella Tarissi de Jacobis, Donato Rigante, Alessandro Rimini, Walter Malorni, Giovanni Corsello, Grazia Bossi, Sabrina Buonuomo, Fabio Cardinale, Elisabetta Cortis and 23 more

Abstract readReview
In one paragraph

Review in Italian journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. [Interpretation of similarities and differences in Kawasaki disease guidelines at home and abroad].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Overview of the rarest causes of fever in newborns: handy hints for the neonatologist.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Alessandra MarchesiBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy. alessandra.marchesi@opbg.net.
Isabella Tarissi de JacobisBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Donato RiganteUniversità Cattolica Sacro Cuore, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
Alessandro RiminiGiannina Gaslini Institute, Genoa, Italy.
Walter MalorniIstituto Superiore di Sanità, Rome, Italy.
Giovanni CorselloUniversità degli Studi di Palermo, Palermo, Italy.
Grazia BossiUniversità degli Studi di Pavia, Pavia, Italy.
Sabrina BuonuomoBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Fabio CardinalePoliclinico Giovanni XXIII, Bari, Italy.
Elisabetta CortisOspedale S. Eugenio, Rome, Italy.
Fabrizio De BenedettiBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Andrea De ZorziBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Marzia DuseUniversità degli Studi Sapienza, Rome, Italy.
Domenico Del PrincipeUniversità degli Studi Tor Vergata, Rome, Italy.
Rosa Maria DellepianeOspedale Maggiore Policlinico, Milan, Italy.
Livio D'IsantoOspedale di Battipaglia, Salerno, Italy.
Maya El HachemBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Susanna EspositoUniversità degli Studi di Perugia, Perugia, Italy.
Fernanda FalciniUniversity of Florence, Florence, Italy.
Ugo GiordanoBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Maria Cristina MaggioUniversità degli Studi di Palermo, Palermo, Italy.
Savina MannarinoUniversità degli Studi di Pavia, Pavia, Italy.
Gianluigi MarsegliaUniversità degli Studi di Pavia, Pavia, Italy.
Silvana MartinoUniversità degli Studi di Torino, Turin, Italy.
Giulia MarucciBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Rossella MassaroAssociazione Rari ma Speciali, Rome, Italy.
Christian PescosolidoAssociazione Rari ma Speciali, Rome, Italy.
Donatella PietraforteIstituto Superiore di Sanità, Rome, Italy.
Maria Cristina PietrograndeOspedale Maggiore Policlinico, Milan, Italy.
Patrizia SaliceOspedale Maggiore Policlinico, Milan, Italy.
Aurelio SecinaroBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.
Elisabetta StrafaceIstituto Superiore di Sanità, Rome, Italy.
Alberto VillaniBambino Gesù Children's Hospital, Piazza S. Onofrio n. 4, 00165, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This second part of practical Guidelines related to Kawasaki disease (KD) has the goal of contributing to prompt diagnosis and most appropriate treatment of KD resistant forms and cardiovascular complications, including non-pharmacologic treatments, follow-up, lifestyle and prevention of cardiovascular risks in the long-term through a set of 17 recommendations.Guidelines, however, should not be considered a norm that limits the treatment options of pediatricians and practitioners, as treatment modalities other than those recommended may be required as a result of peculiar medical circumstances, patient's condition, and disease severity or individual complications.

Indexed as

Drug ResistancePractice Guidelines as TopicAnti-Inflammatory Agents, Non-SteroidalCardiovascular DiseasesChildChild, PreschoolCoronary Artery DiseaseFemaleFollow-Up StudiesHumansImmunoglobulins, IntravenousMaleMucocutaneous Lymph Node SyndromePediatricsRisk AssessmentSeverity of Illness IndexAnti-Inflammatory Agents, Non-SteroidalImmunoglobulins, IntravenousAspirinChildCoronary artery abnormalitiesInnovative biotechnologiesIntravenous immunoglobulinKawasaki diseasePersonalized medicine

Identifiers

PMID30157893
PMCPMC6116479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.